Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Extravasation of diagnostic and therapeutic materials
MeSH D005119 - extravasation of diagnostic and therapeutic materials
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010335:
Pathologic processes
0 Companies
0 Drugs
Success rate
D014947:
Wounds and injuries
34 Companies
12 Drugs
$
Success rate
D005119:
Extravasation of diagnostic and therapeutic materials
11 Companies
9 Drugs
$
Success rate
D000075662:
Injection site reaction
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Clinigen
Dexrazoxane
Savene
2006-07-27
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
3/3
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amphastar Pharmaceuticals
Hyaluronidase
Argenx
Efgartigimod alfa
,
Hyaluronidase
,
Hyaluronidase (human recombinant)
Bausch Health Companies
Hyaluronidase
Genentech
Atezolizumab
,
Hyaluronidase
,
Hyaluronidase (human recombinant)
,
Ocrelizumab
,
Pertuzumab
,
Trastuzumab
,
Trastuzumab emtansine
Johnson & Johnson
Daratumumab
,
Hyaluronidase
,
Hyaluronidase (human recombinant)
Novartis
Phentolamine
Ocuphire Pharma
Phentolamine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use